NetworkNewsBreaks

MondayNov 01, 2021 2:18 pm

NetworkNewsBreaks – Rezolute Inc. (NASDAQ: RZLT) Announces Underwritten Public Offering, Concurrent Registered Direct Offering

Rezolute (NASDAQ: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, has announced the pricing of an underwritten public offering. The offering consists of 6,030,847 shares of its common stock at a public offering price of $6.50 per share and of pre-funded warrants to purchase 1,661,461 shares of its common stock at a public offering price of $6.49 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.01 per share exercise price for each pre-funded warrant. Rezolute also announced the pricing of its concurrent registered…

Continue Reading

MondayNov 01, 2021 1:58 pm

NetworkNewsBreaks – InnerScope Hearing Technologies Inc. (INND) to Be Featured in ‘New to the Street’ Broadcast

InnerScope Hearing Technologies (OTC: INND) will be featured in an upcoming segment of FMW Media’s “New to the Street” nationally syndicated program. The company will be one of four that will be featured on New to the Street’s 259th broadcast, airing at 10:30 p.m. PT on Fox Business Network on Monday, Nov. 1, 2021. InnerScope CEO Matthew Moore will provide viewers information about the company’s emerging and disruptive leadership in the “direct-to-consumer hearing technology” space. Moore explains his successful direct marketing strategy, helping people with access to the company’s hearing aids, which are selling at a fraction of the cost of those sold by…

Continue Reading

MondayNov 01, 2021 1:34 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins R&D Program Comparing DehydraTECH-CBD with Generic CBD, Epidiolex

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has begun a new study, EPIL-A21-1,designed to evaluate whether its DehydraTECH(TM)-CBD (“CBD”) indicates superior ability to reduce seizure activity compared to both generic cannabidiol and Epidiolex. Epidiolex is the only CBD medication approved by the U.S. Food and Drug Administration (“FDA”) for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two rare and severe forms of pediatric epilepsy. Among those involved in the study are respirology and neurobiology experts. According to the announcement, the team of investigators will carefully analyze how DehydraTECH-CBD compares with Epidiolex in treating seizures.…

Continue Reading

MondayNov 01, 2021 12:58 pm

NetworkNewsBreaks – CWCBExpo New York to Showcase Industry Leaders, Dynamic Solutions for Entire Cannabis Ecosystem

CWCBExpo New York today announced details for its upcoming event to take place Nov. 4-6, 2021, at the Javits Center in New York City. According to the update, the recently appointed chair of New York’s Cannabis Control Board, Tremaine Wright, will make her first public presentation at CWCBExpo New York on Nov 4. In addition, on behalf of New York’s Governor Kathy Hochul, Lieutenant Governor Brian A. Benjamin will officially open CWCBExpo New York at its Nov. 4 “Ribbon Cutting Ceremony.” Also in attendance all three days at CWCBExpo New York will be members of the New York State Office…

Continue Reading

MondayNov 01, 2021 12:51 pm

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) on Target to Become House of Brands, Great Channel Partner

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently welcomed former U.S. Congressman and now public policy consultant Ryan Costello to its board of directors. Costello is expected to deepen RWB’s U.S.-based representation, which is key as federal policy on cannabis shifts. The company also announced that it has built a new production facility to good manufacturing practice (“GMP”) specifications in Florida as part of an effort to capitalize on the growing cannabis derivative market there. The Florida facility is built to accommodate the demand for edibles. “Red White & Bloom has built a branded capsule and rosin line…

Continue Reading

MondayNov 01, 2021 12:21 pm

NetworkNewsBreaks – IBN and PsychedelicNewsWire to Broaden Reach for Upcoming Wonderland Miami Conference

IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, today announced that it, together with its PsychedelicNewsWire (“PNW”) brand, will further collaborate with Microdose Psychedelic Insights for the upcoming Wonderland Miami Conference. The event is slated to take place at Miami’s Adrienne Arsht Center for the Performing Arts on Nov. 8-9, 2021. The premier destination for the psychedelic industry, Wonderland: Miami provides an ideal opportunity to connect with influential leaders in science, policy and business. Roger McIntyre, M.D., FRCPC CEO and director, Braxia Scientific (ICX: BRAX), Lamar Odom, former professional American basketball player, and Zappy Zapolin, psychedelic concierge, are among…

Continue Reading

MondayNov 01, 2021 12:01 pm

NetworkNewsBreaks – Sprout AI Inc. (CSE: SPRT) Announces Filing of Q3 Financial Report

Sprout AI (CSE: SPRT), a vertical farming technology company, today announced that it has filed its unaudited interim third quarter (“Q3”) financial statement (“FS”) and management’s discussion and analysis (“MD&A”) for both Sprout AI Inc. (formerly “1262803 B.C. LTD.”) and Sprout AI S.A. (“Sprout AI”). According to the update, both the FS and MD&A represent an amalgamated report concerning both Sprout AI Inc. and Sprout AI S.A. Sprout AI Inc. reported its interim results ending Aug. 31, 2021, in Canadian dollars, while Sprout AI S.A. reported its interim results ending July 31, 2021, in U.S. dollars. Among the Q3 highlights,…

Continue Reading

MondayNov 01, 2021 11:42 am

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leading Way Through Unique Psychedelic Drug Development Focus

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is nearing the launch of a phase 2a clinical trial that aims to establish the value of its psychedelic drug candidate, TRP-8802, in treating chronic and severe eating disorders such as Prader-Willi Syndrome (“PWS”), hypothalamic obesity disorder resulting from the removal of a brain tumor, and binge eating dysfunction. Tryp also plans to execute phase 2b clinical trials for its proprietary psychedelic candidate TRP-8803 to evaluate its ability to penetrate the natural blood-brain barrier and effectively alleviate pain and addiction concerns, including targets for phantom limb pain and fibromyalgia. “Tryp’s product development moves beyond…

Continue Reading

MondayNov 01, 2021 11:39 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Expands Sequire Platform to Launch New Feature

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced the release of the Investor Relations Website Feature. The new feature on Sequire gives issuers the ability to create and customize their own IR website through the platform. “We are adding new features to the Sequire platform all the time, and the ability for issuers to launch their own investor relations websites is a tool that every public company needs. We look forward to helping our clients launch these sites, or transition their existing sites to the…

Continue Reading

MondayNov 01, 2021 11:26 am

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Shines the Spotlight on Vegan Products, Industry Trends and Innovators

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), the digital hub of a thriving plant-based market ecosystem, produces a vodcast series offering weekly insights into vegan products, industry trends and athletes who thrive on a plant-based diet. Through its YouTube channel, the company provides upbeat how-to videos for recipes and fitness practices, as well as news about the state of the industry and PlantX’s investor relations. In addition, PlantX’s blog provides the mortar for binding its community of vegan lifestyle interests together with education to make beneficial habits more accessible. “Over the last 10 years I’ve learned that a…

Continue Reading